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According to the ‘‘osteoblastic niche’’ model, hema-
topoietic stem cells (HSCs) are maintained by N-cad-
herin-mediated homophilic adhesion to osteoblasts
at the bone marrow endosteum. In contrast to this
model, we cannot detect N-cadherin expression by
HSCs, and most HSCs do not localize to the
endosteal surface. It has nonetheless been sug-
gested that HSCs express low levels of N-cadherin
that regulate HSC maintenance. To test this, we
conditionally deleted N-cadherin from HSCs and
other hematopoietic cells in adult Mx-1-Cre+N-cad-
herinfl/ mice. N-cadherin deficiency had no detect-
able effect on HSC maintenance or hematopoiesis.
N-cadherin deficiency did not affect bone marrow
cellularity or lineage composition, the numbers of
colony-forming progenitors, the frequency of HSCs,
the ability of HSCs to sustain hematopoiesis over
time, or their ability to reconstitute irradiated mice
in primary or secondary transplants. Loss of N-cad-
herin does not lead to HSC depletion. N-cadherin
expression by HSCs is not necessary for niche
function.
INTRODUCTION
Hematopoietic stem cells (HSCs) persist throughout adult life in
the bone marrow, where they continuously produce new blood
cells to maintain hematopoiesis. To understand the mechanisms
that sustain HSCs, it is necessary to identify the niche—the
specialized microenvironment in which HSCs are thought to
reside (Adams and Scadden, 2006; Kiel and Morrison, 2008).
Osteoblasts are thought to contribute to HSC niches. Genetic
manipulations that increase osteoblast numbers in mice also
increase the number of HSCs (Calvi et al., 2003; Zhang et al.,
2003). Osteoblasts have also been proposed to secrete factors
that are necessary for HSC maintenance, including angiopoietin,
thrombopoietin, and CXCL12 (Arai et al., 2004; Yoshihara et al.,
2007), although none of these factors have yet been conditionally
deleted from osteoblasts and each is also secreted by other cell
types. Calcium ions from bone (due to osteoblast and osteoclast
activity) also regulate HSC localization and maintenance (Adams
et al., 2006). These observations raise two general possibilities for170 Cell Stem Cell 4, 170–179, February 6, 2009 ª2009 Elsevier Inchow osteoblasts could contribute to HSC maintenance. One
possibility is that osteoblasts produce extracellular factors that
diffuse into the marrow, directly or indirectly regulating HSC
niches that are near, but not at, the endosteum. A second possi-
bility is that osteoblasts directly promote HSC maintenance by
binding HSCs, creating ‘‘osteoblastic niches’’ at the endosteal
surface.
The possibility of bone marrow HSC niches near, but not at,
the endosteum has been raised by a number of recent observa-
tions (Kiel and Morrison, 2008). We have localized HSCs within
the bone marrow using SLAM family markers that give high levels
of stem cell purity and found that few HSCs localize to the endos-
teal surface itself (Kiel et al., 2005, 2007b). Instead, most HSCs
are present around sinusoids, some of which are close to the
endosteum, while others are more distant. It remains uncertain
whether perivascular cells directly promote HSC maintenance;
however, the observation that HSCs are more likely than other
hematopoietic cells to be adjacent to sinusoids (Kiel et al.,
2007b) raises the possibility that there are perivascular niches.
Consistent with this possibility, recent studies have suggested
that perivascular cells, such as reticular cells and mesenchymal
progenitors, express more CXCL12 and angiopoietin than oste-
oblasts (Sugiyama et al., 2006; Sacchetti et al., 2007). This raises
the question of whether HSCs are maintained in direct contact
with osteoblasts, or whether they are maintained in other micro-
environments that are directly or indirectly influenced by factors
secreted by endosteal cells.
The widely discussed osteoblastic niche model has favored
the idea that HSCs are maintained in direct contact with
osteoblasts (Zhang et al., 2003; Suda et al., 2005; Wilson and
Trumpp, 2006; Zhang and Li, 2008). A fundamental element of
this model is that HSCs adhere to the surface of osteoblasts
via N-cadherin-mediated homophilic adhesion and that osteo-
blasts directly promote the maintenance of HSCs by mech-
anisms that involve cell-cell contact, including Notch and
N-cadherin activation (Zhang et al., 2003; Wilson et al., 2004;
Haug et al., 2008). However, genetic evidence supporting such
mechanisms is lacking. Conditional deletion of Jagged1 and/or
Notch1 (the ligand/receptor combination proposed to regulate
Notch signaling between osteoblasts and HSCs) does not affect
HSC maintenance or function (Mancini et al., 2005). Conditional
inactivation of all canonical Notch signaling by disruption of the
CSL/Rbp-J transcriptional complex also does not affect the
maintenance or function of adult HSCs (Maillard et al., 2008). It
remains possible that Notch could regulate HSCs through
some noncanonical signaling pathway, although we are not.
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tested whetherN-cadherin deficiency affects HSC maintenance.
Given the central role proposed for N-cadherin in the creation
of osteoblastic niches, we recently tested whether HSCs
express N-cadherin. We were unable to detect N-cadherin
expression among highly purified HSCs by quantitative PCR,
by staining with commercially available anti-N-cadherin anti-
bodies, or in N-cadherin:LacZ gene trap mice (Kiel et al.,
2007b). Published microarray analyses of HSCs from multiple
laboratories also failed to detect N-cadherin expression (Ivanova
et al., 2002; Kiel et al., 2005). Only bone marrow cells negative for
N-cadherin staining had the capacity to give long-term multiline-
age reconstitution of irradiated mice (Kiel et al., 2007b), even
when we used the commercially available anti-N-cadherin
antibody that had been used to identify osteoblastic niches in
bone marrow sections (Zhang et al., 2003; Wilson et al., 2004).
This suggested that HSCs could not adhere to osteoblasts via
N-cadherin and that the N-cadherin+ cells imaged at the endos-
teum in prior studies could not have been HSCs. However, it was
subsequently suggested that N-cadherin is expressed at low
levels on HSCs and that it remains functionally important for their
localization within a quiescent osteoblastic niche (Haug et al.,
2008; Zhang and Li, 2008).
To resolve this controversy, it was suggested that N-cadherin
should be genetically deleted from adult hematopoietic cells
(Hooper et al., 2007). If N-cadherin is not expressed by HSCs,
then N-cadherin deficiency should not affect HSC maintenance.
In contrast, if HSC niches are regulated by low levels of
N-cadherin expression within HSCs, then N-cadherin deletion
should lead to the depletion of HSCs and to deficits in hemato-
poiesis. We have now addressed this by conditionally deleting
N-cadherin from HSCs and other hematopoietic cells in adult
Mx-1-Cre+N-cadherinfl/ mice. Despite efficient deletion of N-
cadherin from HSCs, these mice exhibited no detectable effects
of N-cadherin deficiency on HSC maintenance or hematopoi-
esis, either acutely after N-cadherin deletion or several months
later. Bone marrow cells from these mice exhibited normal
HSC frequency and a normal capacity to reconstitute irradiated
mice, even upon transplantation into secondary recipients.
N-cadherin is therefore not required cell autonomously to regu-
late HSC maintenance or function. It remains possible that oste-
oblasts regulate HSC maintenance through other mechanisms,
but HSC maintenance does not depend upon N-cadherin-
mediated homophilic adhesion to osteoblasts, as proposed in
current osteoblastic niche models.
RESULTS
N-cadherin Is Efficiently Deleted after pIpC Treatment
Mice with germline N-cadherin deficiency (N-cadherin/) die by
E11 due to severe developmental defects, including cardiovas-
cular failure (Radice et al., 1997). Therefore, to study the effects
of N-cadherin deficiency on adult HSCs, we mated previously
described N-cadherinfl mice (Kostetskii et al., 2005; Luo et al.,
2006; Kadowaki et al., 2007; Li et al., 2008) with Mx-1-Cre
mice (Kuhn et al., 1995) to conditionally delete N-cadherin
from adult HSCs. Each of these strains was backcrossed for at
least six generations onto a C57BL/6 background. Mx-1-CreCexpression is activated in HSCs, other hematopoietic cells,
and some other tissues by administration of polyinosine-polycy-
tidine (pIpC) (Kuhn et al., 1995; Hock et al., 2004; Yilmaz et al.,
2006b).
To test the efficiency of N-cadherin excision within HSCs, we
cultured individual CD150+CD48CD41lineageSca-1+c-kit+
HSCs (1 cell/well) isolated from Mx-1-Cre+N-cadherinfl/ mice
after they had been treated with seven doses of pIpC over 14
days. These cells include more than 95% of all long-term multi-
lineage-reconstituting cells in the bone marrow, and more than
40% of single cells within this population give long-term multili-
neage reconstitution after transplantation into irradiated mice
(Kiel et al., 2005; Yilmaz et al., 2006a; Kiel et al., 2008). Genomic
DNA was extracted from individual myeloerythroid colonies
formed by these HSCs and analyzed by PCR. Of colonies
cultured immediately after pIpC treatment, 53 of 54 showed
complete deletion of N-cadherinfl (Figures 1A and 1B). Of colo-
nies that arose from HSCs cultured 1 to 3 months following
pIpC treatment, 72 of 73 showed complete deletion of the
N-cadherinfl allele (Figures 1A and 1B). This indicates that at least
98% of HSCs deleted N-cadherin upon pIpC treatment. The rare
nonrecombined cells did not appear to have a competitive
advantage over N-cadherin-deficient HSCs, as their frequency
did not increase with time after pIpC treatment.
To ensure the accurate detection of N-cadherin excision, we
sequenced the PCR products corresponding to the wild-type,
floxed, and deleted N-cadherin alleles and confirmed 100%
identity to the appropriate regions of the N-cadherin gene (data
not shown). Moreover, we designed independent PCR primers
that specifically amplified a region of N-cadherin (the first exon)
that is deleted upon Cre-mediated excision and confirmed exci-
sion of the floxed region of N-cadherin in hematopoietic colonies
from pIpC-treated Mx-1-Cre+N-cadherinfl/ mice (Figure S1).
pIpC treatment of Mx-1-Cre+N-cadherinfl/ mice therefore leads
to N-cadherin deletion.
N-cadherin Deficiency Does Not Alter Hematopoiesis
If N-cadherin is critical for HSC maintenance, then N-cadherin
deficiency should lead to defects in hematopoiesis. We therefore
tested whether acute or chronic loss of N-cadherin affected
hematopoiesis in Mx-1-Cre+N-cadherinfl/ mice. To test this,
we harvested peripheral blood and bone marrow from Mx-1-
Cre+N-cadherinfl/ mice or littermate controls (mice lacking Cre
or bearing at least one wild-type allele of N-cadherin) either
immediately following pIpC treatment (2 weeks pIpC; Figures
1C–1G) or 1–3 months following 2 weeks of pIpC administration
(Figures 1H–1L). We did not detect any effect of N-cadherin
deletion on white blood cell (WBC), erythrocyte (RBC), or platelet
(Plts) concentration in the blood of Mx-1-Cre+N-cadherinfl/
mice as compared to littermate controls at either time point
(Figures 1C and 1H). We also did not detect any effect of N-cad-
herin deficiency on bone marrow cellularity (Figures 1D and 1I)
or composition with respect to the erythroid (Ter119+ cells),
myeloid (Mac-1+Gr-1+), B (B220+), or T cell (CD3+) lineages
(Figures 1E and 1J). Finally, we did not detect any effect of N-
cadherin deficiency on the frequency (Figures 1F and 1K) or
types (Figures 1G and 1L) of colony-forming progenitors in the
bone marrow. These results indicate that N-cadherin is not
required within HSCs for hematopoiesis.ell Stem Cell 4, 170–179, February 6, 2009 ª2009 Elsevier Inc. 171
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Frequency or Function In Vivo
To directly test whether N-cadherin deficiency affects HSC
maintenance, we examined the HSC content of bone marrow
isolated from Mx-1-Cre+N-cadherinfl/ mice or littermate
controls either immediately following pIpC treatment (Figures
2A–2C) or 1–3 months later (Figures 2D–2F). As previously re-
ported for wild-type mice (Kiel et al., 2005, 2007a, 2008), the
vast majority of CD150+CD48CD41lineage cells from the
bone marrow of Mx-1-Cre+N-cadherinfl/ mice or littermate
controls were positive for the HSC markers Sca-1 and c-kit
(Figures 2A and 2D). We did not detect any difference in the
frequency (Figure 2B) or absolute number (Figure 2E) of
CD150+CD48CD41lineageSca-1+c-kit+ HSCs in the hin-
dlimb bone marrow of Mx-1-Cre+N-cadherinfl/ mice as
compared to littermate controls. We were also unable to detect
any difference in the frequency or absolute number of Flk2
lineageSca-1+c-kit+ HSCs in Mx-1-Cre+N-cadherinfl/ mice
Figure 1. pIpC Treatment of Adult Mx-1-
Cre+N-cadherinfl/ Mice Led to Efficient
N-cadherin Deletion from HSCs without
Altering Hematopoiesis
(A) CD150+CD48CD41lineageSca-1+c-kit+
bone marrow HSCs from pIpC-treated Mx-1-
Cre+N-cadherinfl/ mice or littermate controls
were cultured in methylcellulose for 14 days, and
then genomic DNA was extracted from the colo-
nies and examined for N-cadherin deletion. (B)
Virtually all of the colonies examined in six
independent experiments from 15 Mx-1-Cre+
N-cadherinfl/ mice showed complete deletion.
Hematopoiesis was examined in Mx-1-Cre+
N-cadherinfl/ mice (black bars) or littermate
controls (white bars) either immediately following
2 weeks of pIpC treatment (C–G) or 1–3 months
following 2 weeks of pIpC administration (H–L).
No statistically significant differences were ob-
served in the concentration of white blood cells
(WBC), erythrocytes (RBC), or platelets (Plts; [C
and H]) from the blood of Mx-1-Cre+N-cadherinfl/
mice as compared to littermate controls. We also
did not observe any differences in bone marrow
cellularity (Dand I), composition (EandJ), frequency
(F and K), or types of colony-forming progenitors
(G and L) in Mx-1-Cre+N-cadherinfl/ mice as
compared to littermate controls. Data are from
two to six mice per treatment in two to three inde-
pendent experiments. All error bars represent SD.
as compared to littermate controls (Fig-
ure 3). Finally, when CD150+CD48
CD41lineageSca-1+c-kit+ HSCs were
individually cultured in methylcellu-
lose, 83%–89% of cells formed large
myeloerythroid colonies irrespective of
whether they were from Mx-1-Cre+
N-cadherinfl/ mice or littermate controls
(Figures 2C and 2F). We therefore could
not detect any effect of N-cadherin
deficiency on the frequency, absolute
number, or colony-forming capacity of
HSCs either immediately after N-cadherin deletion or 1–3
months later.
In case N-cadherin protein turns over slowly or the conse-
quences of its absence only become apparent over long periods
of time, we treated some mice with pIpC for 2 weeks and then
waited for 5 months before analyzing Mx-1-Cre+N-cadherinfl/
mice or littermate controls (Figure 4). Five months after N-cad-
herin deletion, we observed no effect of N-cadherin deficiency
on WBC, RBC, or platelet levels in the blood (Figure 4A) or on
bone marrow cellularity (Figure 4B) or composition (Figure 4C).
We also did not detect any effect of N-cadherin deficiency on
the frequency or absolute number of CD150+CD48CD41linea-
geSca-1+c-kit+ HSCs (Figures 4D and 4E) or Flk2linea-
geSca-1+c-kit+ HSCs (Figures 4F and 4G). These data indicate
that even prolonged absence of N-cadherin does not affect
hematopoiesis or HSC maintenance.
To test whether N-cadherin deficiency affects hematopoietic
recovery after myelosuppression, we administered 5-fluorouracil172 Cell Stem Cell 4, 170–179, February 6, 2009 ª2009 Elsevier Inc.
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following 2 weeks of pIpC administration and analyzed hemato-
poiesis 10 days later. We observed no differences in peripheral
blood cell counts or in the cellularity or composition of the
bone marrow or spleen of Mx-1-Cre+N-cadherinfl/ mice as
compared to littermate controls (Figures S2A and S2C). We
also observed no difference in the frequency or absolute number
of CD150+CD48CD41lineageSca-1+c-kit+ cells in the bone
marrow or spleens of Mx-1-Cre+N-cadherinfl/ mice as
compared to control littermates (Figures S2D and S2H). We
therefore could not detect any effect of N-cadherin deficiency
on hematopoiesis following myelosuppression.
N-cadherin Deficiency Does Not Affect HSC
Maintenance over Time In Vivo
To test whether N-cadherin deficiency affects HSC function
in vivo, we competitively transplanted 13 106 bone marrow cells
from non-pIpC-treated CD45.2+ Mx-1-Cre+N-cadherinfl/ mice
or CD45.2+ littermate controls into lethally irradiated CD45.1+
recipients along with 3 3 105 wild-type CD45.1+ bone marrow
cells. Four weeks following transplantation, we analyzed the
blood of these recipients for engraftment by CD45.2+ donor cells
and found that both Mx-1-Cre+N-cadherinfl/ cells and control
cells had engrafted at similar levels, as expected (Figures 5A,
Figure 2. N-cadherin Deletion Did Not
Affect HSC Frequency or the Ability of
HSCs to Form Colonies in Culture
The frequency of CD150+CD48CD41linea-
geSca-1+c-kit+ cells was examined by flow
cytometry in Mx-1-Cre+N-cadherinfl/ mice (black
bars) or littermate controls (white bars) either
immediately following pIpC administration (A–C)
or 1–3 months later (D–F). No significant differ-
ences were observed in the frequency or absolute
number of CD150+CD48CD41lineageSca-1+
c-kit+ cells contained within the bone marrow of
Mx-1-Cre+N-cadherinfl/ mice as compared to
littermate controls (B and E). When individual
CD150+CD48CD41lineageSca-1+c-kit+ cells
were cultured in methylcellulose, no significant
differences were observed in the percentage of
these cells that formed colonies or in the types of
colonies they formed (C and F). The data are
from six independent experiments with one to
two mice per treatment per experiment. All error
bars represent SD.
5C, and 5E; 4 week time point). Starting
6 weeks after transplantation, we admin-
istered pIpC for 2 weeks to all mice to
delete N-cadherin. If N-cadherin is
required for HSC maintenance or func-
tion in vivo, then we would expect to
observe a loss of donor cells over time
in the mice transplanted with Mx-1-
Cre+N-cadherinfl/ cells, as these cells
should exhibit a competitive disadvan-
tage relative to wild-type HSCs that en-
grafted in the same mice. We monitored
the levels of donor cell reconstitution in
all recipients for a total of 20 weeks after pIpC treatment but
never observed a decline in donor myeloid (Mac-1+; Figures 5A
and 5B), B (B220+; Figures 5C and 5D), or T cells (CD3+; Figures
5E and 5F) in recipients of Mx-1-Cre+N-cadherinfl/ cells. To
ensure thatN-cadherin had been efficiently deleted in this exper-
iment, we performed PCR on genomic DNA from donor-derived
Mac-1+ myeloid cells isolated from the peripheral blood of these
recipients. We observed complete excision of N-cadherin from
the myeloid cells collected from recipients of Mx-1-Cre+N-cad-
herinfl/ cells but not recipients of control cells (Figure 5G). These
results indicate that N-cadherin is not required for the mainte-
nance of HSC function in vivo and that N-cadherin-deficient
HSCs are not at a competitive disadvantage relative to wild-
type cells.
N-cadherin Is Not Required for HSC Reconstitution
of Irradiated Recipients
If N-cadherin is required for HSC homing or engraftment in the
niche, then deletion of N-cadherin from HSCs prior to transplan-
tation should cause an engraftment defect. To test this, we
treated CD45.2+ Mx-1-Cre+N-cadherinfl/ mice or littermate
controls with pIpC and then transplanted 1 3 106 bone marrow
cells 3 months later along with 3 3 105 recipient bone marrow
cells into CD45.1+ recipient mice. All of the recipients of bothCell Stem Cell 4, 170–179, February 6, 2009 ª2009 Elsevier Inc. 173
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became long-term multilineage reconstituted by donor myeloid,
B, and T cells (Figure 6A). The level of reconstitution by donor
cells did not differ between recipients of Mx-1-Cre+N-cadher-
infl/ cells and control cells in terms of all donor blood cells
(CD45.2+, Figure 6B, p = 0.16), donor myeloid cells (Mac-1+,
Figures 6C and 6D, p = 0.18), B cells (B220+, Figures 6E and
6F, p = 0.19), or T cells (CD3+, Figures 6G and 6H, p = 0.16).
N-cadherin is therefore not required for the homing or engraft-
ment of HSCs in vivo.
To even more stringently test whether N-cadherin deficiency
affects HSC function in vivo, we also performed secondary
transplants from the primary recipients described in Figure 5.
Twenty-eight weeks after transplantation into the primary recip-
ients, we transplanted 1 3 106 bone marrow cells from primary
recipients of CD45.2+ Mx-1-Cre+N-cadherinfl/ mice or CD45.2+
littermate controls into lethally irradiated CD45.1+ secondary
recipients along with 3 3 105 wild-type CD45.1+ bone marrow
Figure 3. N-cadherin Deficiency Did Not Affect the Frequency of
Flk2lineageSca-1+c-kit+ HSCs in the Bone Marrow
Representative flow cytometry plots of bone marrow cells from Mx-1-Cre+
N-cadherinfl/ mice or littermate controls after 2 weeks of pIpC administration
(A and B). No significant difference was observed in the frequency of Flk2
lineageSca-1+c-kit+ cells within the bone marrow of Mx-1-Cre+N-cadherinfl/
mice as compared to littermate controls (B). These data are from two indepen-
dent experiments with two to three mice of each genotype per experiment.
Error bars represent SD.174 Cell Stem Cell 4, 170–179, February 6, 2009 ª2009 Elsevier Inc.cells. We monitored the blood of the secondary recipients for
engraftment by CD45.2+ donor myeloid (Mac-1+; Figures 7A
and 7B), B (B220+; Figures 7C and 7D), and T cells (CD3+;
Figures 7E and 7F) for a total of 17 weeks after transplantation.
We found no difference in the level of donor cell engraftment
between mice that receivedMx-1-Cre+N-cadherinfl/ donor cells
as compared to control cells in any lineage. To ensure that mice
were reconstituted by N-cadherin-deficient donor cells, we per-
formed PCR on genomic DNA from CD45.2+ myeloid cells iso-
lated from the peripheral blood of these recipients. As expected,
we observed complete excision of N-cadherin from the donor
myeloid cells collected from recipients of Mx-1-Cre+N-cadher-
infl/ cells (Figure 7G).
We also performed another secondary transplant experiment
using the mice shown in Figure 6 (mice in which N-cadherin was
deleted prior to transplantation into the primary recipients). Four
primary recipients of N-cadherin-deficient cells (averaging 74%
± 13% of white blood cells that were donor derived) and four
primary recipients of control cells (averaging 75% ± 8% of white
blood cells that were donor derived) were selected for secondary
transplantation. Twenty-eight weeks after transplantation into
the primary recipients, 3 3 106 bone marrow cells from each
primary recipient were transplanted into irradiated secondary
recipients (five to six secondary recipients per primary recipient).
Sixteen weeks later, all of the secondary recipients were found
to have high levels of multilineage reconstitution by donor cells, ir-
respectiveof the genotypeof the donor cells.Secondary recipients
ofN-cadherin-deficient cells averaged 72% ± 24% of white blood
cells thatweredonor derived,while secondary recipientsofcontrol
cells averaged 65% ± 26% of white blood cells that were donor
derived. Together with the results in Figure 7, these results indicate
thatN-cadherin is not required for the maintenance of HSCs in vivo
and that N-cadherin deficiency does not affect the ability of HSCs
to reconstitute primary or secondary recipient mice.
DISCUSSION
The ‘‘osteoblastic niche’’ model proposes that HSCs are
maintained in direct contact with osteoblasts via N-cadherin-
mediated homophilic adhesion (Zhang et al., 2003; Arai et al.,
2004; Wilson et al., 2004; Suda et al., 2005; Wilson and Trumpp,
2006; Haug et al., 2008; Zhang and Li, 2008). According to this
model, N-cadherin is postulated to be required within HSCs to
maintain adhesion with the niche, to regulate quiescence, to
regulate b-catenin signaling, and to maintain HSCs in an undif-
ferentiated state (Zhang et al., 2003; Arai et al., 2004; Wilson
et al., 2004; Suda et al., 2005; Wilson and Trumpp, 2006; Haug
et al., 2008; Zhang and Li, 2008). However, these predictions
have not been tested in N-cadherin-deficient mice. Our data
demonstrate that N-cadherin deletion in vivo from HSCs and
other hematopoietic cells has no effect on hematopoiesis in
the bone marrow (Figures 1 and 4), HSC frequency (Figures 2,
3, and 4), HSC maintenance, or function over time (Figure 5),
or on the ability of HSCs to engraft and reconstitute irradiated
mice in primary or secondary transplants (Figures 6 and 7). In
no assay did N-cadherin-deficient HSCs show a competitive
disadvantage relative to wild-type HSCs. N-cadherin is therefore
not required autonomously within HSCs to regulate their mainte-
nance or function.
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HSCs are maintained as a result of cell-cell contact with osteo-
blasts. HSCs were originally localized to the surface of osteo-
blasts based on staining for N-cadherin+ bromodeoxyuridine
(BrdU) label-retaining cells (Zhang et al., 2003). However, in addi-
tion to being unable to detect N-cadherin expression within
HSCs by several different techniques (Kiel et al., 2007b), we
have also found that BrdU label retention has very poor speci-
ficity and very poor sensitivity as an HSC marker: the vast
majority of HSCs fail to retain BrdU for long periods of time,
and the vast majority of bone marrow cells that do retain BrdU
are not HSCs (Kiel et al., 2007a). When we localize highly purified
HSCs within bone marrow sections using SLAM family markers,
we find a minority of HSCs that localize near the endosteal
surface (<20%) and a majority of HSCs (>60%) that localize to
sinusoids that are not at the endosteal surface (Kiel et al.,
2005, 2007b). It thus remains possible that a subset of HSCs is
maintained in niches that are at, or near, the endosteum by
N-cadherin-independent mechanisms, but it seems unlikely
that all HSCs depend on contact with osteoblasts for their main-
tenance. Rather, our data (Kiel et al., 2005, 2007b) and the data
of others (Sugiyama et al., 2006; Sacchetti et al., 2007) raise the
possibility of perivascular niches for HSCs, although direct
evidence that perivascular cells promote HSC maintenance is
also lacking. It is also important to note that, even if a subset
of HSCs reside in perivascular niches, these niches may depend
Figure 4. Prolonged N-cadherin Deficiency
Did Not Affect HSC Frequency or Hemato-
poiesis
In case N-cadherin protein turns over slowly or the
consequences of its absence only become ap-
parent over long periods of time, we treated some
mice with pIpC for 2 weeks then waited for 5
months before analyzing Mx-1-Cre+N-cadherinfl/
mice (black bars) or littermate controls (white
bars). No statistically significant difference was
observed in the concentration of white blood cells
(WBC), erythrocytes (RBC), or platelets (Plts; [A])
from the blood of Mx-1-Cre+N-cadherinfl/ mice
as compared to littermate controls. We also
observed no difference in bone marrow cellularity
(B), lineage composition (C), frequency (D), or
absolute number (E) of CD150+CD48CD41
lineageSca-1+c-kit+ HSCs, or frequency (F) or
absolute number (G) of Flk2lineageSca-1+
c-kit+ HSCs. The data are from two to four mice
per genotype. All error bars represent SD.
on factors secreted by osteoblasts for
their creation or maintenance.
A recent study from Li and colleagues
(Haug et al., 2008) used an anti-N-cad-
herin antibody, MNCD2 (Matsunami and
Takeichi, 1995), that was not used in
prior studies of HSCs to suggest that
HSCs do express N-cadherin at low
levels and that this antibody can be
used to resolve HSCs into two popula-
tions: an N-cadherinlow population that
contains long-term multilineage-reconstituting activity and
a distinct N-cadherinintermediate ‘‘reserve’’ population that resides
within the osteoblastic niche. However, the N-cadherinlow
staining was not clearly distinct from background, and the
N-cadherinintermediate population had little HSC activity in recon-
stitution assays. We have independently tested the MNCD2 anti-
body and fail to detect staining of HSCs above background
(Figure S3) irrespective of the age of mice used for HSC isolation
(Figure S4) or whether the HSCs were isolated by collagenase
digestion of the bones followed by staining with MNCD2 in the
presence of calcium (Figure S5). Finally, we readily detect
N-cadherin expression by 30,000 neonatal forebrain cells by
western blot, but we have been unable to detect N-cadherin
expression within 100,000 whole bone marrow cells or 100,000
LineageSca-1+c-kit+ cells in the same western blots (Figures
S7–S9). These results are consistent with our previously reported
conclusion that N-cadherin expression cannot be detected in
HSCs (Kiel et al., 2007b).
The recent study from Li and colleagues (Haug et al., 2008)
used MNCD2 to evaluate N-cadherin expression by HSCs using
flow cytometry, even though the specificity of MNCD2 antibody
for N-cadherin has only ever been tested by western blot (Radice
et al., 1997; Haug et al., 2008). In an attempt to resolve the
discrepancies between our results and their results, we tested
the specificity of MNCD2 antibody by flow cytometry. We
observe staining of some bone marrow cells with the MNCD2Cell Stem Cell 4, 170–179, February 6, 2009 ª2009 Elsevier Inc. 175
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HSC Maintenance Is Not Regulated by N-Cadherinantibody by flow cytometry (Figure S3), particularly among
B220+ B cells that express surface IgM (sIgM; Figure S6).
However, the MNCD2 staining of bone marrow cells by flow
cytometry was not affected by N-cadherin deletion (Figures S3
and S6), and we did confirm that MNCD2-stained bone marrow
cells had deleted N-cadherin by PCR of genomic DNA
(Figure S6C). This suggests that MNCD2 staining by flow cytom-
etry does not reflect N-cadherin expression. We readily detected
N-cadherin by western blot in 30,000 neonatal forebrain cells
using MNCD2 (Figures S7–S9). However, neither 100,000
sIgM+ B cells (Figure S7) nor 100,000 of the bone marrow cells
that stained with MNCD2 by flow cytometry (Figure S9) exhibited
Figure 5. N-cadherin Deficiency Did Not Affect HSCMaintenance or
Function In Vivo
Bone marrow cells (1 3 106) from CD45.2+ Mx-1-Cre+N-cadherinfl/ mice
(black dots) or CD45.2+ littermate controls (white dots) were injected into
lethally irradiated CD45.1+ wild-type recipients along with 3 3 105 CD45.1+
bone marrow cells. pIpC was administered to all recipients for 2 weeks
(shaded area) beginning 6 weeks after transplantation. Reconstitution by
donor cells was then monitored for an additional 20 weeks. We observed no
decline in reconstitution by donor myeloid (Mac-1+; [A and B]), B (B220+;
[C and D]), or T (CD3+; [E and F]) cells, indicating that N-cadherin deletion
did not affect HSC maintenance, function, or the ability to compete with
wild-type HSCs. Each line represents a single recipient mouse. Data from
one representative experiment are shown with average donor chimerism levels
in each lineage shown at week 28 after transplantation (B, D, and F). Two inde-
pendent experiments with a total of nine recipients per genotype gave similar
results. After 28 weeks, donor Mac-1+ myeloid cells were isolated from the
blood of representative recipients and analyzed for N-cadherin deletion:
recipients of Mx-1-Cre+N-cadherinfl/ cells appeared to be reconstituted
entirely by N-cadherin-deficient cells (G). Error bars represent SD.176 Cell Stem Cell 4, 170–179, February 6, 2009 ª2009 Elsevier Inc.detectable N-cadherin expression by western blot using
MNCD2. This indicates that MNCD2 staining reflects something
other than N-cadherin in the bone marrow by flow cytometry. Our
results indicate that MNCD2 antibody cannot be used to reliably
detect N-cadherin by flow cytometry.
Our results by western blot are thus consistent with the results
that we have obtained by microarray analysis, qPCR, flow cy-
tometry, and analysis of N-cadherin gene trap mice in indicating
that N-cadherin is not expressed by HSCs (Kiel et al., 2007b).
It remains possible that N-cadherin deficiency in osteoblasts
could affect HSC maintenance or hematopoiesis, at least indi-
rectly. Expression of dominant-negative N-cadherin (that may
affect other cadherins as well) in osteoblasts leads to a reduction
in trabecular bone and defects in osteoblast maturation (Cheng
et al., 2000). Effects on hematopoiesis have not yet been tested
in these mice, but it is possible that defects in osteogenesis
could lead to changes in HSC frequency or hematopoiesis.
Nonetheless, many direct and indirect mechanisms could
potentially account for such effects (Kiel and Morrison, 2008),
so this would not provide evidence that HSCs are maintained
via N-cadherin-mediated adhesion with osteoblasts.
Many potential models of the HSC niche remain compatible
with existing data, and there is little experimental basis on which
to favor any specific model (Kiel and Morrison, 2008; Morrison
and Spradling, 2008). One possibility is that HSCs reside in
niches near the endosteum that are created through the
combined action of factors secreted by endosteal, perivascular,
and potentially other cells. Another possibility is that HSCs reside
primarily in perivascular niches, at least some of which are close
to the endosteum and potentially influenced by factors secreted
by endosteal cells. A third possibility is that there are spatially
distinct niches in the bone marrow, some of which are close to
the endosteum while others are not. These possibilities are not
mutually exclusive and are not the only possibilities. Although
some have recently proposed that it may be possible to distin-
guish between cells that reside in perivascular versus endosteal
niches, there is little direct experimental support for this idea.
Moreover, this model is conceptually problematic given that
the endosteum is among the most highly vascularized sites in
the bone marrow: HSCs cannot localize to the endosteum
without being perivascular. To more clearly define the niche it
will be necessary to genetically determine the physiologically




C57BL/Ka-Thy-1.1 (CD45.2) and C57BL/Ka-Thy-1.2 (CD45.1) mice were
housed in the Unit for Laboratory Animal Medicine at the University of Michi-
gan. Both Mx-1-Cre mice and N-cadherinfl/ mice were backcrossed for at
least six generations onto a C57BL/6 background. In every experiment, litter-
mate control mice were gender matched and either lacked Mx-1-Cre or had at
least one wild-type allele of N-cadherin.
pIpC Administration
pIpC was administered to mice as previously described (Yilmaz et al., 2006b).
Briefly, pIpC was resuspended in Dulbecco’s phosphate-buffered saline
(D-PBS) at 2 mg/ml, and mice were injected with 25 mg per gram of bodyweight
every other day for 14 days.
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HSC Maintenance Is Not Regulated by N-CadherinFigure 6. N-cadherinDeficiency Did Not Affect the Ability of HSCs to
Engraft or to Reconstitute Irradiated Recipients
pIpC was administered toMx-1-Cre+N-cadherinfl/ mice or littermate controls.
Three months later, 1 3 106 bone marrow cells from CD45.2+ Mx-1-Cre+N-
cadherinfl/ mice (black bars) or littermate controls (white bars) were injected
into lethally irradiated CD45.1+ wild-type recipients along with 3 3 105
CD45.1+ bone marrow cells. All recipients became long-term multilineage
reconstituted by donor cells ([A], n = 10–12 recipients per genotype). The levels
of reconstitution 16 weeks after transplantation are shown. N-cadherin
deficiency did not affect the levels of reconstitution by CD45+ donor cells
([B], p = 0.16) or by donor cells in the myeloid (Mac-1+, [C and D], p = 0.18),
B (B220+, [E and F], p = 0.19), or T (CD3+, [G and H], p = 0.16) cell lineages.
Four different control littermates and four different Mx-1-Cre+N-cadherinfl/
donors were separately transplanted into a total of 10 to 12 recipients per
genotype. Error bars represent SD. N-cadherin-deficient cells from these
mice also did not differ from control cells in their capacity to reconstitute
irradiated secondary recipients (data not shown; see text).CFlow Cytometry and the Isolation of HSCs
Bone marrow cells were flushed from the long bones (tibias and femurs) with
Hank’s buffered salt solution without calcium or magnesium, supplemented
with 2% heat-inactivated calf serum (GIBCO, Grand Island, NY; HBSS+). Cells
were triturated and filtered through nylon screen (45 mm, Sefar America, Kan-
sas City, MO) to obtain a single-cell suspension.
For isolation of Flk2lineageSca-1+c-kit+ cells, whole bone marrow cells
were incubated with PE-conjugated monoclonal antibodies to lineage markers
including B220 (6B2), CD3 (KT31.1), CD4 (GK1.5), CD8 (53-6.7), Gr-1 (8C5),
Mac-1 (M1/70), Ter119, and IgM in addition to FITC-conjugated anti-Sca-1
(Ly6A/E; E13-6.7) and PE-Cy5-conjugated or biotin-conjugated anti-c-kit
(2B8). An antibody against Flk-2 (A2F10.1) was used to isolate Flk-2 progeni-
tors.Biotin-conjugated c-kit stainingwasvisualized usingstreptavidin APC-Cy7.
Figure 7. N-cadherin Deficiency Did Not Affect HSC Function upon
Serial Transplantation into Secondary Recipients
As shown in Figure 5, irradiated CD45.1+ primary recipient mice were reconsti-
tuted with 1 3 106 CD45.2+ Mx-1-Cre+N-cadherinfl/ (black dots) or CD45.2+
littermate control (white dots) bone marrow cells then treated with pIpC to
delete N-cadherin. Twenty-eight weeks after transplantation, 1 3 106 bone
marrow cells from these mice were transplanted into irradiated CD45.1+
secondary recipients along with 33 105 CD45.1+ bone marrow cells. The levels
of donor cell reconstitution in these secondary recipients were unaffected byN-
cadherin deficiency in the myeloid (A and B), B (C and D), and T (E and F) cell
lineages. Each line represents a single recipient mouse. Data shown are from
one representative experiment in which cells from two pIpC-treated primary
recipients of Mx-1-Cre+N-cadherinfl/ cells and one pIpC-treated primary
recipient of control littermate cells were transplanted into two to three
secondary recipients each. Two independent experiments with a total of nine
to ten secondary recipients and three primary donors per genotype gave similar
results. After 17 weeks, donor Mac-1+ myeloid cells were isolated from the
blood of representative recipients and analyzed for N-cadherin deletion: recip-
ients of Mx-1-Cre+N-cadherinfl/ cells appeared to be reconstituted by donor
cells that were entirely N-cadherin deficient (G). Error bars represent SD.ell Stem Cell 4, 170–179, February 6, 2009 ª2009 Elsevier Inc. 177
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marrow cells were incubated with PE-conjugated anti-CD150 (TC15-
12F12.2; BioLegend, San Diego, CA), FITC-conjugated anti-CD48 (HM48-1;
BioLegend), FITC-conjugated anti-CD41 (MWReg30; BD PharMingen, San
Diego, CA), biotin-conjugated or APC-conjugated anti-Sca-1 (Ly6A/E; E13-
6.7), and PE-Cy5-conjugated anti-c-kit (2B8) antibody, in addition to anti-
bodies against the following FITC-conjugated lineage markers: Ter119, B220
(6B2), Gr-1 (8C5), and CD2 (RM2-5). Biotin-conjugated Sca-1 was visualized
using streptavidin-conjugated APC-Cy7. HSCs were sometimes pre-enriched
by selecting Sca-1+ or c-kit+ cells using paramagnetic microbeads and auto-
MACS (Miltenyi Biotec, Auburn, CA). Biotin-conjugated MNCD2 anti-
N-cadherin antibody was obtained from Dr. Linheng Li and stored at 20C.
Nonviable cells were excluded from sorts and analyses using the viability
dye DAPI (1 mg/ml).
Long-Term Competitive Repopulation Assay
Adult recipient mice (CD45.1) were irradiated with an Orthovoltage X-ray
source delivering approximately 300 rad/min in two equal doses of 570 rad,
delivered at least 2 hr apart. Cells were injected into the retro-orbital venous
sinus of anesthetized recipients. Each recipient mouse received 3 3 105
CD45.1 marrow cells for radioprotection. Beginning 4 weeks after trans-
plantation and continuing for at least 16 weeks, blood was obtained from
the tail veins of recipient mice, subjected to ammonium-chloride potassium
red cell lysis, and stained with directly conjugated antibodies to CD45.2
(104, FITC), B220 (6B2), Mac-1 (M1/70), CD3 (KT31.1), and Gr-1 (8C5) to
monitor engraftment.
N-Cadherin Excision Analysis
Genomic DNA from individual CD150+CD48CD41lineageSca-1+c-kit+
HSC colonies or Mac-1+ peripheral blood cells was isolated by phenol-chloro-
form extraction. Glycogen (Roche, Indianapolis IN) was used to enhance the
recovery of the DNA. PCR products were separated using 2% agarose gels
to confirm the presence or absence of bands corresponding to wild-type,
floxed, or deleted alleles. Primer sequences for amplification of N-cadherin
alleles were as described previously (Kostetskii et al., 2005): N-cadherin
NC23, 50-GTATGGCCAAGTAATGGGGAC; N-cadherin L07, 50-TGCTGGTAG
CATTCCTATGG; and N-cadherin L08, 50-TACAAGTTTGGGTGACAAGC.
Methylcellulose Culture
Sorted bone marrow cells and twice-sorted HSCs were plated in individual
wells of 96-well plates (Corning, Corning NY) containing 100 ml 1.0% methylcel-
lulose (Stem Cell Technologies, Vancouver, BC) as previously described. The
methylcellulose was supplemented with 1% penicillin/streptomycin (GIBCO),
50 ng/ml stem cell factor (SCF), 10 ng/ml interleukin-3 (IL-3), 10n g/ml inter-
leukin-6 (IL-6), and 3 U/ml erythropoietin (Epo). Colonies were maintained at
37C in humidified incubators at 6% O2. Colony formation was scored after
10–14 days of culture.
SUPPLEMENTAL DATA
The Supplemental Data include Supplemental Experimental Procedures and
nine figures and can be found with this article online at http://www.cell.com/
cell-stem-cell/supplemental/S1934-5909(08)00528-6.
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Note Added in Proof
While this paper was in press, Nature Biotechnology published a study by
Foudi et al. (2008) that also concluded that MNCD2 antibody cannot be
used to distinguish HSCs into subsets with distinct cell-cycle activities and
that this antibody does not recognize N-cadherin by flow cytometry.
Foudi, A., Hochedlinger, K., Van Buren, D., Schindler, J.W., Jaenisch, R.,
Carey, V., and Hock, H. (2008). Analysis of histone 2B-GFP retention reveals
slowly cycling hematopoietic stem cells. Nat. Biotechnol. Published online
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